Human Genome Epidemiology Literature Finder
Records 1 - 6 (of 6 Records) |
Query Trace: Neutropenia and APC[original query] |
---|
Impact of CYP3A4 haplotypes on irinotecan pharmacokinetics in Japanese cancer patients. Cancer chemotherapy and pharmacology 2008 Aug 62 (3): 529-37. Sai Kimie, Saito Yoshiro, Fukushima-Uesaka Hiromi, Kurose Koichi, Kaniwa Nahoko, Kamatani Naoyuki, Shirao Kuniaki, Yamamoto Noboru, Hamaguchi Tetsuya, Kunitoh Hideo, Ohe Yuichiro, Tamura Tomohide, Yamada Yasuhide, Minami Hironobu, Ohtsu Atsushi, Yoshida Teruhiko, Saijo Nagahiro, Sawada Jun-ic |
Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Jun 27 (16): 2604-14. Innocenti Federico, Kroetz Deanna L, Schuetz Erin, Dolan M Eileen, Ramírez Jacqueline, Relling Mary, Chen Peixian, Das Soma, Rosner Gary L, Ratain Mark |
Uridine diphosphate glucuronosyl transferase 1 family polypeptide A1 gene (UGT1A1) polymorphisms are associated with toxicity and efficacy in irinotecan monotherapy for refractory pancreatic cancer. Cancer chemotherapy and pharmacology 2013 Jan 71 (1): 85-92. Takahara Naminatsu, Nakai Yousuke, Isayama Hiroyuki, Sasaki Takashi, Satoh Yumiko, Takai Daiya, Hamada Tsuyoshi, Uchino Rie, Mizuno Suguru, Miyabayashi Koji, Mohri Dai, Kawakubo Kazumichi, Kogure Hirofumi, Yamamoto Natsuyo, Sasahira Naoki, Hirano Kenji, Ijichi Hideaki, Tada Minoru, Yatomi Yutaka, Koike Kazuhi |
OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapy. British journal of cancer 2015 Mar 112 (5): 857-65. Teft W A, Welch S, Lenehan J, Parfitt J, Choi Y-H, Winquist E, Kim R |
Impact of genetic polymorphisms determining leukocyte/neutrophil count on chemotherapy toxicity. The pharmacogenomics journal 2018 04 18 (2): 270-274. Glisovic S J, Pastore Y D, Gagne V, Plesa M, Laverdière C, Leclerc J M, Sinnett D, Krajinovic |
Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology 2018 01 29 (1): 139-144. Overman M J, Adam L, Raghav K, Wang J, Kee B, Fogelman D, Eng C, Vilar E, Shroff R, Dasari A, Wolff R, Morris J, Karunasena E, Pisanic T R, Azad N, Kopetz |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: